Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWalker Crips Regulatory News (WCW)

  • This share is currently suspended. It was suspended at a price of 13.50
  • There is currently no data for WCW

Working Capital Loan Drawdown Facility

31 Jul 2025 17:45

RNS Number : 4922T
Walker Crips Group plc
31 July 2025
 

 

 

Walker Crips Group plc

 

("Walker Crips" or the "Company")

 

Working Capital Loan Drawdown Facility Secured

 

Walker Crips announces that it has secured a £5m Working Capital Loan Drawdown Facility ('Facility') from its largest shareholder, Phillip Brokerage Pte Ltd ('PhillipCapital'). The Facility provides the Company with necessary funding to support its future plans and reinforce the Company's financial stability.

 

The Facility is for a maximum of £5m, with a fixed term of 2 years from 31 July 2025. Interest will only be charged on the amount drawn down at 9.07% per annum, and there is a one-off Facility Fee of 1% (£50,000). Other than the one-off Facility Fee, there will be no other costs if no drawdown has been made. The Facility can be repaid at any time without penalty.

 

If any amount of the Facility (including accrued but unpaid interest) remains drawn down six months from the date of the agreement, the Company will be required to initiate a rights issue for the purpose of repayment of the Facility. If the Facility is undrawn or is drawn and repaid in full (including accrued interest) as at 31 January 2026 then there will be no requirement for the Company to initiate a rights issue. The Company intends to repay any drawn amounts ahead of 31 January 2026.

 

The Company requires this funding in light of an especially challenging last financial year, as announced in the Company's full year results to 31 March 2025. As a result of a number of historic issues, there has been a requirement both to fund substantial investment in legal and consulting services, as well as the recruitment of additional Compliance personnel. The Facility has therefore been put in place to reinforce the Company's financial position following significant expenditure, and will be utilised to support the Company's growth plans in the near term.

 

Jo Welman, Chairman, commented: "We have secured a £5m loan facility from PhillipCapital, one of our major shareholders, to provide the necessary funding to support our future plans and reinforce the Group's financial stability. The availability of this loan is instrumental, without it, the Group would lack the capacity to implement essential changes and invest in the growth strategies required to move our business forward. We continue to actively explore a broad range of strategic options aimed at further strengthening our balance sheet and positioning the Group for long-term success."

 

Additional information

 

Phillip Brokerage PTE Ltd and its connected parties hold 12,359,803 shares in the Company, equivalent to 29.03% per cent. of the Company's issued share capital. As a result of its shareholding in the Company, Phillip Brokerage PTE Ltd is defined as a related party under the UK Listing Rules ("UKLRs") and the provision of the Facility constitutes a related party transaction under paragraph 8.2.1R of the UKLRs.

 

The Board (comprised for these purposes of all directors with the exception of Hua Min Lim and Linus Lim) confirms its view that the provision of the Facility is fair and reasonable as far as the shareholders of Walker Crips are concerned and that the Board has been so advised by Singer Capital Markets in its role as the Company's sponsor in connection with the Facility.

 

 

For further information, please contact:

 

Walker Crips Group plc

Craig Harrison, Media Relations

Tel: +44 (0)20 3100 8000

Singer Capital Markets

Charles Leigh-Pemberton / Asha Chotai

Tel: +44 (0)20 7496 3000

 

 

Further information on Walker Crips Group is available on the Company's website: www.walkercrips.co.uk

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBLGDRIDXDGUB
Date   Source Headline
31st Jul 20204:00 pmRNSAppointment of Broker
31st Jul 20203:47 pmRNSFinal Results
15th Jun 20207:00 amRNSDirector/PDMR Shareholding
24th Dec 201911:15 amRNSDirector/PDMR Shareholding
27th Nov 20197:00 amRNSHalf-year Report
26th Nov 201912:55 pmRNSDirector/PDMR Shareholding
13th Nov 20193:05 pmRNSDirector/PDMR Shareholding
3rd Oct 201912:12 pmRNSDirector/PDMR Shareholding
2nd Oct 20192:05 pmRNSSecond Price Monitoring Extn
2nd Oct 20192:00 pmRNSPrice Monitoring Extension
24th Sep 20197:00 amRNSManagement Changes
23rd Sep 20194:30 pmRNSDirector/PDMR Shareholding
4th Sep 20193:00 pmRNSResult of AGM
4th Sep 20198:30 amRNSBoard Changes
22nd Aug 20199:30 amRNSDirector/PDMR Shareholding
31st Jul 20195:19 pmRNSDirector/PDMR Shareholding
31st Jul 201910:20 amRNSDirector/PDMR Shareholding
29th Jul 20192:40 pmRNSDirector/PDMR Shareholding
11th Jul 201912:03 pmRNSFinal Results
27th Jun 20195:20 pmRNSDirector/PDMR Shareholding
29th May 201912:01 pmRNSDirector/PDMR Shareholding
21st May 20195:15 pmRNSDirector/PDMR Shareholding
8th May 201911:30 amRNSDirector/PDMR Shareholding
27th Mar 20196:30 pmRNSDirector/PDMR Shareholding
13th Mar 20195:53 pmRNSReplacement Director/PDMR Shareholding
13th Mar 201912:53 pmRNSDirector/PDMR Shareholding
7th Mar 20194:52 pmRNSDirector/PDMR Shareholding
4th Mar 20198:44 amRNSDirector/PDMR Shareholding
1st Mar 20193:56 pmRNSDirector/PDMR Shareholding
26th Feb 20194:00 pmRNSTrading Update
12th Feb 20194:56 pmRNSDirector / PDMR Shareholdings
30th Jan 20197:00 amRNSBoard changes
17th Dec 201812:00 pmRNSDirector/PDMR Shareholding
27th Nov 20188:36 amRNSHalf-year Report - Replacement
27th Nov 20187:00 amRNSResults for the six months ended 30 September 2018
29th Oct 201811:25 amRNSDirector/PDMR Shareholding
11th Oct 20182:53 pmRNSDirector/PDMR Shareholding
20th Sep 201811:10 amRNSDirector/PDMR Shareholding
14th Sep 20185:24 pmRNSDirector/PDMR Shareholding
5th Sep 20184:33 pmRNSResult of AGM
31st Jul 20184:08 pmRNSFinal Results
8th Jun 20183:28 pmRNSDirector/PDMR Shareholding
25th May 20187:00 amRNSIssue of Equity and Total Voting Rights
26th Apr 20188:20 amRNSHolding(s) in Company
18th Apr 20185:34 pmRNSDirector/PDMR Shareholding
21st Mar 20187:00 amRNSHolding(s) in Company
6th Mar 20185:36 pmRNSHolding(s) in Company
19th Feb 20183:30 pmRNSDirector/PDMR Shareholding
9th Feb 20184:55 pmRNSDirectorate Change
4th Jan 201810:10 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.